Advertisement
Home Tags CORO

Tag: CORO

Trump Administration Reverses Plan to End Free COVID Test Program

0
By India Edwards HealthDay Reporter WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The Trump administration changed course on Tuesday, deciding to keep the government's free...

Americans Still Consider COVID Major Public Health Threat

0
By Dennis Thompson HealthDay Reporter THURSDAY, Jan. 30, 2025 (HealthDay News) -- People still see COVID-19 as an ongoing public health threat, even though the...

CIA Now Backs Lab Leak Theory for COVID-19, but Confidence Remains Low

0
By India Edwards HealthDay Reporter MONDAY, Jan. 27, 2025 (HealthDay News) -- After years of speculation, the CIA has weighed in yet again: A lab...

Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity

0

Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during omicron era

Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2

0

Increased risk seen for incident AIRD for patients with SARS-CoV-2, with higher risk seen after more severe acute COVID-19

White House Lifts COVID Testing Rule for People Around President Biden

0
By Robin Foster HealthDay Reporter TUESDAY, March 5, 2024 (HealthDay News) -- In a move that acknowledges that COVID-19 is no longer the danger it...

0.1 to 0.5 Percent of SARS-CoV-2 Infections Become Persistent

0

In some individuals, there were many viral amino acid substitutions, indicating strong positive selection

CDC May Recommend COVID Boosters for Some This Spring

0
By Robin Foster HealthDay Reporter FRIDAY, Feb. 16, 2024 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention is weighing whether to recommend...

Updated COVID-19 Vaccine Has Effectiveness of 54 Percent

0

Vaccine effectiveness 49 percent at 60 to 119 days after vaccination among tests exhibiting spike gene target failure

Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions

0

Severely immunocompromised individuals had greater SARS-CoV-2 evolution, higher risk for developing resistance against therapeutic mAbs